Polycystic ovary syndrome

被引:965
作者
Azziz, Ricardo [1 ,2 ]
Carmina, Enrico [3 ]
Chen, ZiJiang [4 ,5 ]
Dunaif, Andrea [6 ]
Laven, Joop S. E. [7 ]
Legro, Richard S. [8 ]
Lizneva, Daria [1 ,9 ]
Natterson-Horowtiz, Barbara [10 ]
Teede, Helena J. [11 ,12 ]
Yildiz, Bulent O. [13 ]
机构
[1] Augusta Univ, Dept Obstet & Gynecol, Med Coll Georgia, 1120 15th St,CB-2209, Augusta, GA 30912 USA
[2] Augusta Univ, Med Coll Georgia, Dept Med, Augusta, GA USA
[3] Univ Palermo, Dept Hlth Sci & Mother & Child Care, Palermo, Italy
[4] Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan, Peoples R China
[5] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China
[6] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
[7] Erasmus MC, Div Reprod Med, Dept OBGYN, Rotterdam, Netherlands
[8] Penn State Univ, Coll Med, Dept Obstet & Gynecol, Hershey, PA USA
[9] Sci Ctr Family Hlth & Human Reprod, Dept Reprod Hlth Protect, Irkutsk, Russia
[10] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA
[11] Monash Univ, Monash Ctr Hlth Res & Implementat, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia
[12] Monash Hlth, Clayton, Vic, Australia
[13] Hacettepe Univ, Div Endocrinol & Metab, Dept Internal Med, Sch Med, Ankara, Turkey
关键词
QUALITY-OF-LIFE; ANTI-MULLERIAN HORMONE; IMPAIRED GLUCOSE-TOLERANCE; FOLLICLE-STIMULATING-HORMONE; DEPENDENT DIABETES-MELLITUS; GENOME-WIDE ASSOCIATION; IN-VITRO FERTILIZATION; INTIMA-MEDIA THICKNESS; FAMILY-BASED ANALYSIS; INSULIN-RESISTANCE;
D O I
10.1038/nrdp.2016.57
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide. The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology (PCOM)-with excessive androgen production by the ovaries being a key feature of PCOS. Metabolic dysfunction characterized by insulin resistance and compensatory hyperinsulinaemia is evident in the vast majority of affected individuals. PCOS increases the risk for type 2 diabetes mellitus, gestational diabetes and other pregnancy-related complications, venous thromboembolism, cerebrovascular and cardiovascular events and endometrial cancer. PCOS is a diagnosis of exclusion, based primarily on the presence of hyperandrogenism, ovulatory dysfunction and PCOM. Treatment should be tailored to the complaints and needs of the patient and involves targeting metabolic abnormalities through lifestyle changes, medication and potentially surgery for the prevention and management of excess weight, androgen suppression and/or blockade, endometrial protection, reproductive therapy and the detection and treatment of psychological features. This Primer summarizes the current state of knowledge regarding the epidemiology, mechanisms and pathophysiology, diagnosis, screening and prevention, management and future investigational directions of the disorder.
引用
收藏
页数:18
相关论文
共 233 条
[1]
Three decades after Gjonnaess's laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach [J].
Abu Hashim, Hatem ;
Al-Inany, Hesham ;
De Vos, Michel ;
Tournaye, Herman .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (02) :409-422
[2]
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women [J].
Alvarez-Blasco, Francisco ;
Botella-Carretero, Jose I. ;
San Millan, Jose L. ;
Escobar-Morreale, Hector F. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (19) :2081-2086
[3]
Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis [J].
Anderson, Sarah A. ;
Barry, John A. ;
Hardiman, Paul J. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (02) :486-487
[4]
Is ovarian reserve diminished after laparoscopic ovarian drilling? [J].
Api, Murat .
GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (03) :159-165
[5]
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span [J].
Azziz, R ;
Marin, C ;
Hoq, L ;
Badamgarav, E ;
Song, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4650-4658
[6]
LEUPROLIDE AND ESTROGEN VERSUS ORAL-CONTRACEPTIVE PILLS FOR THE TREATMENT OF HIRSUTISM - A PROSPECTIVE RANDOMIZED STUDY [J].
AZZIZ, R ;
OCHOA, TM ;
BRADLEY, EL ;
POTTER, HD ;
BOOTS, LR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3406-3411
[7]
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245
[8]
New insights into the genetics of polycystic ovary syndrome [J].
Azziz, Ricardo .
NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (02) :74-75
[9]
Polycystic ovary syndrome: an ancient disorder? [J].
Azziz, Ricardo ;
Dumesic, Daniel A. ;
Goodarzi, Mark O. .
FERTILITY AND STERILITY, 2011, 95 (05) :1544-1548
[10]
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488